Access Preprint From Server
January 22nd, 2025
Version: 1
Citizen Scientist
bioinformatics
biorxiv

Inferring circadian rhythm disruptions in cancer using phase differences between clock genes

Zhang, Z.

Circadian rhythms exist across various levels of biological activities, from molecular processes to behaviors. Circadian clock genes are closely linked to the onset and progression of cancer; however, systematic analysis of their rhythmic expression in human tumors is still lacking due to difficulties in time-series sampling. In this study, we examined and improved the method for inferring phase differences through clock gene co-expression to investigate circadian rhythms in timestamp-free samples. We found that the co-expression levels of rhythmic genes are primarily determined by phase differences and are influenced by the strength and tissue specificity of rhythmic expression. Thus, we identified evolutionarily conserved rhythmic genes across multiple tissues to construct tissue-specific phase difference matrices. On this basis, we developed a method for inferring phase difference variations and extended it to the single-sample level as ssDistance to evaluate circadian rhythm disruptions in tumors. The results showed that significant changes in phase differences between clock genes in tumors exhibit cancer-type specificity and have complex effects on patient survival. Results revealed that the significant alterations in phase differences between clock genes in tumors are cancer-type-specific and have complex effects on patient survival. This method provides an effective tool for studying circadian rhythms in large-scale public datasets lacking temporal information.

Similar Papers

biorxiv
Sat Apr 05 2025
FootprintCharter: unsupervised detection and quantification of footprints in single molecule footprinting data
Single molecule footprinting profiles the heterogeneity of TF occupancy at cis-regulatory elements across cell populations at unprecedented resolution. The single molecule nature of the data in principle allows for observing the footprint of individual transcription factors and nucleosomes. However, we currently lack algorithms to quantify these occupancy patterns of chromatin binding factors in a...
Barzaghi, G.
•
Krebs, A. R.
•
Zaugg, J. B.
biorxiv
Sat Apr 05 2025
Training data composition determines machine learning generalization and biological rule discovery
Supervised machine learning models depend on training datasets with positive and negative examples. Therefore, dataset composition directly impacts model performance and bias. Given the importance of machine learning for immunotherapeutic design, we examined how different negative class definitions affect model generalization and rule discovery for antibody-antigen binding. Using synthetic structu...
Ursu, E.
•
Minnegalieva, A.
•
Rawat, P.
•
Chernigovskaya, M.
...•
Greiff, V.
biorxiv
Sat Apr 05 2025
Cumulating MS Signal enables polyclonal antibody analysis
Unraveling the complexities of protein systems via Mass Spectrometry (MS), particularly polyclonal antibodies, demands innovative analytical strategies. Here, we introduce the cumulative MS score (cMS), a novel mathematical framework that transcends traditional spectrum-matching, integrating MS evidence across multiple sample injections to achieve robust de novo peptide sequencing annotation. This...
Gueto-Tettay, C. A.
•
Strobaek, J.
•
Tang, D.
•
Gomez Toledo, A.
...•
Malmstrom, L.
biorxiv
Sat Apr 05 2025
Dissecting Opioid Effects in Cell-Cell Communication Within the Ventral Tegmental Area
Opioid use disorders (OUD) exacerbate the complexity of neurocognitive impairments and neurodevelopmental disorders, with poorly understood molecular mechanisms at the intercellular communication level. This study utilized single-nuclei RNA sequencing (snRNA-seq) data from the SCORCH program, examining brain samples from 95 donors, including individuals with and without a history of opioid abuse, ...
Chen, Y.
•
Ho, W.-Z.
•
Wei, Z.
biorxiv
Sat Apr 05 2025
PEAS: Detection of Clustered Differences in Genomic Data
Motivation: Studies of genetically-distinct individuals have shown that differences in marks of transcriptional regulation such as chromatin accessibility , transcription factor binding and histone modifications are often proximally clustered along the genome. These proximal clusters, which have been labeled as cis-regulatory domains (CRDs), are thought to reflect topological features of the genom...
Skola, D. D.
•
Glass, C.
biorxiv
Sat Apr 05 2025
SCORCH2: a generalised heterogeneous consensus model for high-enrichment interaction-based virtual screening
The discovery of effective therapeutics remains a complex, costly, and time-consuming endeavor, characterized by high failure rates and significant resource investments. A central bottleneck in early-stage drug discovery is identifying suitable hit compounds with moderate affinity for known biological targets. Although advancements have been made, current in silico virtual screening methods are su...
Chen, L.
•
Blay, V.
•
Ballester, P. J.
•
Houston, D. R.
biorxiv
Sat Apr 05 2025
HyDrop v2: Scalable atlas construction for training sequence-to-function models
Deciphering cis-regulatory logic underlying cell type identity is a fundamental question in biology. Single-cell chromatin accessibility (scATAC-seq) data has enabled training of sequence-to-function deep learning models allowing decoding of enhancer logic and design of synthetic enhancers. Training such models requires large amounts of high-quality training data across species, organs, developmen...
Dickmänken, H.
•
Wojno, M.
•
Theunis, K.
•
Eksi, E. C.
...•
Aerts, S.
biorxiv
Sat Apr 05 2025
NeSyDPP4-QSAR: A Neuro-Symbolic AI Approach for Potent DPP-4-Inhibitor Discovery in Diabetes Treatment
Diabetes Mellitus (DM) is a global epidemic and among the top ten leading causes of mortality (WHO, 2019), projected to rank seventh by 2030. The US National Diabetes Statistics Report (2021) states that 38.4 million Americans have diabetes. Dipeptidyl Peptidase-4 (DPP-4) is an FDA-approved target for type 2 diabetes mellitus (T2DM) treatment. However, current DPP-4 inhibitors are associated with ...
Hossain, D.
•
Chen, J. Y.
biorxiv
Sat Apr 05 2025
SpaceBF: Spatial coexpression analysis using Bayesian Fused approaches in spatial omics datasets
Advancements in spatial omics technologies have enabled the measurement of expression profiles of different molecules, such as genes (using spatial transcriptomics), and peptides, lipids, or N-glycans (using mass spectrometry imaging), across thousands of spatial locations within a tissue. While identifying molecules with spatially variable expression is a well-studied statistical problem, robust ...
Seal, S.
•
Neelon, B.
biorxiv
Sat Apr 05 2025
Unified integration of spatial transcriptomics across platforms
Spatial transcriptomics (ST) has transformed our understanding of tissue architecture and cellular interactions, but integrating ST data across platforms remains challenging due to differences in gene panels, data sparsity, and technical variability. Here, we introduce LLOKI, a novel framework for integrating imaging-based ST data from diverse platforms without requiring shared gene panels. LLOKI ...
Haber, E.
•
Deshpande, A.
•
Ma, J.
•
Krieger, S.